Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-08 Sale |
2025-04-08 7:40 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
2,708 | $14.82 | $40,133 | 64,732 (Direct) |
View |
2025-03-26 Sale |
2025-03-26 8:06 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
3,171 | $17.05 | $54,066 | 218,738 (Direct) |
View |
2025-02-24 Sale |
2025-02-25 6:46 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
773 | $19.96 | $15,429 | 53,882 (Direct) |
View |
2024-11-19 Sale |
2024-11-19 8:40 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
10,259 | $16.81 | $172,454 | 73,128 (Direct) |
View |
2024-08-19 Sale |
2024-08-20 6:46 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
9,733 | $15.28 | $148,720 | 43,735 (Direct) |
View |
2024-06-10 Sale |
2024-06-11 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
975 | $14.79 | $14,420 | 34,564 (Direct) |
View |
2024-05-02 Sale |
2024-05-03 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
3,503 | $16.94 | $59,341 | 52,498 (Direct) |
View |
2024-04-08 Sale |
2024-04-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
2,716 | $17.87 | $48,535 | 39,293 (Direct) |
View |
2024-03-27 Sale |
2024-03-27 7:57 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
5,434 | $17.9 | $97,269 | 131,461 (Direct) |
View |
2024-02-26 Sale |
2024-02-27 6:13 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
772 | $24.67 | $19,045 | 22,420 (Direct) |
View |
2023-11-20 Sale |
2023-11-21 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
5,108 | $22.64 | $115,645 | 60,138 (Direct) |
View |
2023-08-21 Sale |
2023-08-23 7:31 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
10,000 | $29 | $289,970 | 15,682 (Direct) |
View |
2023-06-08 Sale |
2023-06-12 8:48 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
974 | $25.02 | $24,369 | 24,717 (Direct) |
View |
2023-05-17 Sale |
2023-05-19 6:48 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
15,310 | $22.5 | $344,475 | 71,469 (Direct) |
View |
2023-04-06 Sale |
2023-04-07 8:37 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
1,916 | $18.16 | $34,795 | 23,303 (Direct) |
View |
2023-02-24 Sale |
2023-02-27 9:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
577 | $18.78 | $10,836 | 6,824 (Direct) |
View |
2022-06-09 Sale |
2022-06-10 8:51 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
653 | $17.91 | $11,695 | 7,128 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 5:43 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer |
553 | $23.8 | $13,161 | 6,161 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-05 Exercise |
2025-04-08 7:40 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
5,275 | $0 | 64,732 (Direct) |
View |
2025-03-25 Exercise |
2025-03-26 8:06 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
6,178 | $0 | 218,738 (Direct) |
View |
2025-03-24 Option Award |
2025-03-26 8:06 pm |
N/A 2035-03-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
143,313 | $0 | 218,738 (Direct) |
View |
2025-02-23 Exercise |
2025-02-25 6:46 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
1,353 | $0 | 53,882 (Direct) |
View |
2024-11-17 Exercise |
2024-11-19 8:40 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
19,826 | $0 | 73,128 (Direct) |
View |
2024-08-16 Option Award |
2024-08-20 6:46 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
18,904 | $0 | 43,735 (Direct) |
View |
2024-06-08 Exercise |
2024-06-11 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
1,893 | $0 | 34,564 (Direct) |
View |
2024-05-01 Exercise |
2024-05-03 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
6,814 | $0 | 52,498 (Direct) |
View |
2024-04-05 Exercise |
2024-04-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
5,275 | $0 | 39,293 (Direct) |
View |
2024-03-25 Option Award |
2024-03-27 7:57 pm |
N/A 2034-03-24 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
115,828 | $0 | 131,461 (Direct) |
View |
2024-02-23 Exercise |
2024-02-27 6:13 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
1,353 | $0 | 22,420 (Direct) |
View |
2023-11-17 Exercise |
2023-11-21 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
9,912 | $0 | 60,138 (Direct) |
View |
2023-06-08 Exercise |
2023-06-12 8:48 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
1,893 | $0 | 24,717 (Direct) |
View |
2023-05-17 Exercise |
2023-05-19 6:48 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
29,738 | $0 | 71,469 (Direct) |
View |
2023-05-01 Option Award |
2023-05-03 9:15 pm |
N/A 2033-05-01 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
117,195 | $0 | 117,195 (Direct) |
View |
2023-04-05 Exercise |
2023-04-07 8:37 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
5,275 | $0 | 23,303 (Direct) |
View |
2023-02-23 Exercise |
2023-02-27 9:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
1,353 | $0 | 6,824 (Direct) |
View |
2022-06-08 Exercise |
2022-06-10 8:51 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
1,893 | $0 | 7,128 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 6:49 pm |
N/A 2032-04-05 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
93,515 | $0 | 93,515 (Direct) |
View |
2022-02-23 Exercise |
2022-02-25 5:43 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer |
1,352 | $0 | 6,161 (Direct) |
View |
Ownership |
2021-12-20 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer |
0 | $0 | 152,688 (Direct) |
View |